Trials / Completed
CompletedNCT04372420
Bone Morphogenetic Protein-2 In Grade II Furcation Defects.
Recombinant Human Bone Morphogenetic Protein-2 In Absorbable Sponge Vs Platelet Rich Fibrin (PRF) In Grade Ii Furcation Defects - A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- SVS Institute of Dental Sciences · Academic / Other
- Sex
- All
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The present study evaluated clinically and radiographically the regenerative potential of rhBMP-2 in absorbable sponge and PRF in Grade II furcation.
Detailed description
44 subjects were enrolled in the study. PPD, CAL, plaque index and gingival index were recorded and the evaluation of bone fill was performed after 6 months by using ImageJ® software. After 6 months, the bone fill obtained with rhBMP-2 was higher when compared to PRF. From this trial conducted over a period of 6 months, the unique properties associated with rhBMP-2 in absorbable sponge makes it a potential agent to be used as a graft material for Grade II furcation defects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RhBMP-2 absorbable sponge in grade II furcation | The collagen sponge is impregnated with rhBMP-2 at a concentration of 0.5 μg/ml/1cm3 and were stored at 4°C. This rhBMP-2 impregnated collagen sponge was then dispensed at grade II furcation site |
| PROCEDURE | PLATELET RICH FIBRIN in grade II furcation | For preparation of PRF, patient's venous blood is collected into 10ml glass tube or glass-coated plastic tube and centrifuged at 2700 rpm for 12min which leads to two different layers in the test tube, the upper platelet rich fibrin and the lower RBC portion. The formed PRF clot could then be removed from the glass tube and used in grade II furcation |
Timeline
- Start date
- 2017-12-05
- Primary completion
- 2019-09-19
- Completion
- 2019-10-10
- First posted
- 2020-05-04
- Last updated
- 2020-05-05
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT04372420. Inclusion in this directory is not an endorsement.